112. A Novel Oncolytic Adenovirus Based on Human Adenovirus Serotype 17

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)33717-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Novel Adenovirus Vaccine Vectors Based on the Enteric-Tropic Serotype 41

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2007English

Human Adenovirus Serotype 3 Vector Packaged by a Rare Serotype 14 Hexon

PLoS ONE
Multidisciplinary
2016English

A Novel Ad5/11 Chimeric Oncolytic Adenovirus for Improved Glioma Therapy

International Journal of Oncology
Cancer ResearchOncology
2012English

Ad3-hTERT-E1a, a Fully Serotype 3 Oncolytic Adenovirus, in Patients With Chemotherapy Refractory Cancer

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2012English

Radiosensitization by Telomerase-Dependent Oncolytic Adenovirus

Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
2011English

Subversion of CtBP1-controlled Macropinocytosis by Human Adenovirus Serotype 3

EMBO Journal
ImmunologyMolecular BiologyBiochemistryMicrobiology NeuroscienceMedicineGenetics
2008English

A Novel Oncolytic Adenovirus Targeting to Telomerase Activity in Tumor Cells With Potent

Oncogene
Cancer ResearchGeneticsMolecular Biology
2004English

Potent Immune Responses and in Vitro Pro-Inflammatory Cytokine Suppression by a Novel Adenovirus Vaccine Vector Based on Rare Human Serotype 28

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2010English

Novel Human Adenovirus Causing Nosocomial Epidemic Keratoconjunctivitis

Journal of Clinical Microbiology
Microbiology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy